(Q37138439)

18 August 2017

1 reference

title

Diagnostic flow cytometry for low-grade myelodysplastic syndromes (English)

1 reference

18 August 2017

0 references

1 reference

Kiyoyuki Ogata

1

1 reference

18 August 2017

publication date

1 December 2008

1 reference

18 August 2017

published in

Hematological Oncology

1 reference

18 August 2017

volume

26

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

193-198

1 reference

Proposals for the classification of the myelodysplastic syndromes

18 August 2017

cites work

1 reference

Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.

21 January 2018

1 reference

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

7 January 2021

Myelodysplastic syndromes: recent progress in diagnosis and understanding of their pathophysiology

1 reference

7 January 2021

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

7 January 2021

Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics

1 reference

7 January 2021

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

1 reference

7 January 2021

Flow cytometry in myelodysplastic syndromes: report from a working conference

1 reference

7 January 2021

Enalapril (MK-421) and the white cell count and haematocrit

1 reference

7 January 2021

Antihypertensive medications and anemia

1 reference

7 January 2021

Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice

1 reference

7 January 2021

Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data.

1 reference

7 January 2021

Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosis

1 reference

7 January 2021

Immunologic indices in myelodysplastic syndromes

1 reference

7 January 2021

High Ia (HLA-DR) and low CD11b (Mo1) expression may predict early conversion to leukemia in myelodysplastic syndromes

1 reference

7 January 2021

Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes

1 reference

7 January 2021

Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns

1 reference

7 January 2021

CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes

1 reference

7 January 2021

Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes

1 reference

7 January 2021

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

1 reference

7 January 2021

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

1 reference

7 January 2021

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls

1 reference

7 January 2021

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

1 reference

7 January 2021

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

1 reference

7 January 2021

Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome

1 reference

7 January 2021

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

1 reference

7 January 2021

Clinical implications of blast immunophenotypes in myelodysplastic syndromes

1 reference

7 January 2021

Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes.

1 reference

7 January 2021

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry

1 reference

7 January 2021

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome.

1 reference

7 January 2021

Immunotyping of blasts in refractory anaemia with excess of blasts.

1 reference

7 January 2021

Acute leukemic transformation of myelodysplastic syndrome--immunophenotypic, genotypic, and cytogenetic studies

1 reference

7 January 2021

Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.

1 reference

7 January 2021

Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common

1 reference

7 January 2021

Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.

1 reference

7 January 2021

Effect of time, temperature, and anticoagulant on flow cytometry and hematological values

1 reference

7 January 2021

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures

1 reference

7 January 2021

CD7 expression by CD34+ cells in CML patients, of prognostic significance?

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.857

1 reference

18 August 2017

1 reference